Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.19.2
Accrued Expenses
3 Months Ended
Jun. 30, 2019
Payables and Accruals [Abstract]  
Accrued Expenses

Accrued expenses are composed of the following at June 30, 2019 and March 31, 2019:

 

     June 30,      March 31,  
     2019      2019  
             
 Accrued expenses for AV-101, PH94B, and PH10            
      clinical trial, development and related expenses   $ 1,643,600     $ 1,067,600  
 Accrued compensation     -       439,200  
 Accrued professional services     195,700       172,100  
 All other     7,700       6,700  
    $ 1,847,000     $ 1,685,600